Back to Journals » Drug Design, Development and Therapy » Volume 3
Review
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,904 | Dovepress* | 8,904+ | 3,063 | 11,967 | |
Totals | 8,904 | 3,063 | 11,967 | ||
*Since 27 March 2009 +Since July 2016 |
View citations on Google Scholar